HomeEarly Access Programs

Early Access

Our Early Access Programs (often called Expanded Access, Pre-approval Access, Compassionate Use, Named Patient or Managed Access Programs) deliver potentially lifesaving treatments to patients around the world, while adding true value to our clients through a range of in-house additional cutting-edge services.

A unique offering.

Bionical Emas EAP is the only specialist Early Access Program (EAP) partner to harness the full power of an established and successful Clinical Research Organization. Our global EAP experience in Oncology and Rare disease areas is perfectly complemented by a range of in-house services.

Bionical Emas EAP team provide our clients a superior experience for the benefit of healthcare professionals and patients around the world.

We put the patient at the heart of everything we do. Our goal is to help current and future generations providing timely and appropriate treatment access to patients in desperate need.

Our in-house services include:

  • EAP strategy and program design
  • Global regulatory expertise
  • Full pharmacovigilance services
  • Medical Information and Medical Affairs services
  • Industry-standard setting request management solutions
  • Real-World Evidence generation and utilization
  • Tried and tested clinical Quality Management Systems, state-of-the-art warehouse facilities, quality assurance and full licence structure

What is an EAP?.

We are delivering potentially life-saving treatments to patients around the world through our programs. We remind ourselves of this every day and, in turn, it drives our service levels to our clients. Through the generation of real-world evidence, we also know we are benefiting future patients in parallel

Tom Watson, EVP – Early Access Programs

Case studies.

Global EAP for a specialised Biotech company Play Video
European EAP with tailored RWD strategy Play Video
Global early access program takeover Play Video

How can we support you?

If you are a Healthcare Professional seeking access to a Bionical Emas EAP product, or for further information on partnering with Bionical Emas EAP

COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.